THYROCARE TECHNOLOGIES
Back to Cashflow Statement
|
THYROCARE TECHNOLOGIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-130 Cr | ₹-85 Cr | ₹-86 Cr | ₹-89 Cr | ₹-62 Cr |
What is the latest Cash Flow from Financing Activities ratio of THYROCARE TECHNOLOGIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-130 Cr |
| Mar2024 | ₹-85 Cr |
| Mar2023 | ₹-86 Cr |
| Mar2022 | ₹-89 Cr |
| Mar2021 | ₹-62 Cr |
How is Cash Flow from Financing Activities of THYROCARE TECHNOLOGIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-130 Cr | Negative | |
| Mar2024 | ₹-85 Cr | Negative | |
| Mar2023 | ₹-86 Cr | Negative | |
| Mar2022 | ₹-89 Cr | Negative | |
| Mar2021 | ₹-62 Cr | - | |
Compare Cash Flow from Financing Activities of peers of THYROCARE TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THYROCARE TECHNOLOGIES | ₹7,312.9 Cr | -1% | 5.2% | 74.8% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹98,165.4 Cr | -6.1% | -2.7% | 1.7% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹97,752.6 Cr | -2.7% | -6.6% | -5.5% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹63,752.4 Cr | -7.4% | -5.2% | 29.2% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹37,108.9 Cr | -6.7% | -4.8% | 38.8% | Stock Analytics | |
| GLOBAL HEALTH | ₹28,174.6 Cr | -9.9% | -10.3% | 4.8% | Stock Analytics | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | -1% |
5.2% |
74.8% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses